Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Microbiology|October 5, 2012
Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterizationPaul A Kristiansen, Fabien Diomandé, Rasmata Ouédraogo, et al.
Clinical and Vaccine Immunology : CVI|February 16, 2007
Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7Gunnstein Norheim, Abraham Aseffa, Mohammed Ahmed Yassin, et al.
Ebiomedicine|March 9, 2019
Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016Nadav Topaz, Dominique A Caugant, Muhamed-Kheir Taha, et al.
Innate Immunity|March 22, 2019
Molecular studies of meningococcal and pneumococcal meningitis patients in EthiopiaWude Mihret, Berit Sletbakk Brusletto, Reidun Øvstebø, et al.
BMC Genomics|May 24, 2017
Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in ChadKanny Diallo, Kadija Gamougam, Doumagoum M Daugla, et al.
The Journal of Infection|April 30, 2017
Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal InitiativeRay Borrow, Dominique A Caugant, Mehmet Ceyhan, et al.
The Lancet. Microbe|April 13, 2024
Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance studyDaniel Golparian, Michelle J Cole, Leonor Sánchez-Busó, et al.
Clinical and Vaccine Immunology : CVI|March 14, 2008
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococciGunnstein Norheim, Abraham Aseffa, Mohammed Ahmed Yassin, et al.
Vaccine|March 10, 2005
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal diseaseJohan Holst, Berit Feiring, Lisbeth M Naess, et al.
Plos Neglected Tropical Diseases|December 3, 2008
Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in UgandaPhilippe J Guerin, Lisbeth M Naess, Carole Fogg, et al.
Pageof 16